This study is testing a new drug called SBS-147 to see how safe it is and how your body handles it. Researchers are also looking for any side effects. You might receive SBS-147 or a placebo (a substance with no medicine) to help compare results fairly. This study is for healthy adults aged 18 to 55. The main goal is to understand what medical problems participants might have while taking SBS-147. Some participants will take SBS-147 or placebo once, while others will take it once or twice daily for 7 days. The study aims to enroll 80 participants.

Study design

This is an interventional study involving 80 healthy adult participants. Some will receive SBS-147, and others will receive a placebo.

What's involved

You would stay at the clinic for 5 days for the single-dose group, or 10 days for the multiple-dose group. This includes tests, blood draws, and questionnaires, with a final visit on Day 8 or Day 14.

Compensation

Not stated in the trial record.

Follow-up

Participants in the single-dose group will have an end-of-study visit on Day 8. Participants in the multiple-dose group will have an end-of-study visit on Day 14.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.